Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04053283 |
Title | First in Human Study With NG-641, an Oncolytic Transgene Expressing Adenoviral Vector |
Acronym | STAR |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | PsiOxus Therapeutics Ltd |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |